Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralipid in Recurrent Implantation Failure
NCT02865785Phase 2Unknown
- Sponsor
- Ain Shams University
- Start
- Jul 2016
- Primary completion
- Jul 2017
- Countries
- 1
01
Overview
A Phase 2 trial of Intralipid 10% in Recurrent Implantation Failure (RIF), sponsored by Ain Shams University. Status: unknown.
02
Drugs
Intralipid 10%
03
Conditions
Recurrent Implantation Failure (RIF)
Beyond the preview
Go deeper on NCT02865785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02865785.